The PM Society Digital Awards 2024, an annual event in the healthcare marketing industry sponsored by Twist Health, held its ...

Olorofim is licensed in Europe and Asia to Japanese pharma Shionogi, which paid $100 million upfront for rights to the drug ...

The $25 million award from the Advanced Research Projects Agency for Health (ARPA-H) will be used to develop Cellino's NEBULA ...

The facility at a business park in Raheen, Limerick, was first announced in 2022 and this is the second time that Lilly has ...

It's known that excessive use of earbuds at high volumes can cause hearing loss, so somewhat ironic that the FDA has just ...

UK biotech F2G has raised $100 million as it prepares to refile its olorofim candidate for invasive fungal infections, which ...

GSK has abandoned its clinical-stage vaccine for herpes simplex virus (HSV) after a disappointing phase 1/2 trial, ceding the ...

There are no FDA-approved therapies for this age group, although, Wegovy has been cleared since 2022 for use in children and ...

Sanofi and Regeneron have celebrated a pair of positive clinical trials in inflammatory skin disorders with blockbuster ...

Moderna said the changes will reduce the cumulative spend on R&D between 2025 and 2028 to $16 billion from $20 billion, and ...

GSK's new long-acting drug candidate for severe asthma, depemokimab, reduced the rate of severe attacks by 54% in a pair of ...

The US House of Representatives comprehensively voted in favour of the BIOSECURE Act, which will prohibit businesses in the ...